Principal Investigator
Charles H. Eger, MD is a board-certified internist who recently retired from practicing medicine for over 35 years to conduct clinical research with Velocity. Joining the team in September 2022, Dr. Eger already has broad expertise in conducting clinical trials, studying vaccines for COVID-19, influenza, RSV, and combinations, as well as novel treatments for Hypertension and other cardiovascular therapeutic areas. Outside of clinical research, Dr. Eger serves on a volunteer board for Christian Villages Communities, a retirement community in Cincinnati.
